- Home
- ACEL vs NUVB Comparison
ACEL vs NUVB Comparison
Compare ACEL & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACEL
- NUVB
- Stock Information
- Founded
- ACEL 2009
- NUVB 2018
- Country
- ACEL United States
- NUVB United States
- Employees
- ACEL N/A
- NUVB N/A
- Industry
- ACEL Services-Misc. Amusement & Recreation
- NUVB Biotechnology: Pharmaceutical Preparations
- Sector
- ACEL Consumer Discretionary
- NUVB Health Care
- Exchange
- ACEL Nasdaq
- NUVB Nasdaq
- Market Cap
- ACEL 934.8M
- NUVB 837.0M
- IPO Year
- ACEL N/A
- NUVB N/A
- Fundamental
- Price
- ACEL $11.16
- NUVB $3.27
- Analyst Decision
- ACEL Buy
- NUVB Strong Buy
- Analyst Count
- ACEL 1
- NUVB 6
- Target Price
- ACEL $16.00
- NUVB $8.17
- AVG Volume (30 Days)
- ACEL 326.6K
- NUVB 6.5M
- Earning Date
- ACEL 10-29-2025
- NUVB 11-05-2025
- Dividend Yield
- ACEL N/A
- NUVB N/A
- EPS Growth
- ACEL N/A
- NUVB N/A
- EPS
- ACEL 0.40
- NUVB N/A
- Revenue
- ACEL $1,279,563,000.00
- NUVB $14,355,000.00
- Revenue This Year
- ACEL $9.99
- NUVB $332.80
- Revenue Next Year
- ACEL $5.17
- NUVB $360.12
- P/E Ratio
- ACEL $28.42
- NUVB N/A
- Revenue Growth
- ACEL 7.00
- NUVB 900.35
- 52 Week Low
- ACEL $9.02
- NUVB $1.54
- 52 Week High
- ACEL $13.28
- NUVB $4.09
- Technical
- Relative Strength Index (RSI)
- ACEL 43.89
- NUVB 58.62
- Support Level
- ACEL $10.99
- NUVB $3.23
- Resistance Level
- ACEL $11.41
- NUVB $3.44
- Average True Range (ATR)
- ACEL 0.25
- NUVB 0.24
- MACD
- ACEL 0.00
- NUVB 0.00
- Stochastic Oscillator
- ACEL 21.21
- NUVB 34.66
About ACEL Accel Entertainment Inc.
Accel Entertainment Inc is a distributed gaming and local entertainment operator in the United States. It is engaged in the installation, maintenance, operation, and servicing of gaming terminals and related equipment, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and amusement devices in authorized non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. The Company also operates stand-alone ATMs in gaming and non-gaming locations. It generates revenue from Net gaming, Amusement, Manufacturing, ATM fees, and others.
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.